SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,428.95 -210.08
( -0.27%)

Global Indices

Nasdaq

53,210.99 704.96
(1.34%)

Dow Jones

7,621.51 110.79
(1.48%)

Hang Seng

63,983.92 229.02
(0.36%)

Nikkei 225

10,890.39 32.69
(0.30%)

Forex

USD-INR

95.40 -0.19
(-0.20%)

EUR-INR

110.00 0.21
(0.19%)

GBP-INR

128.60 0.50
(0.39%)

JPY-INR

0.61 0.01
(2.47%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Concord Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543960

INE338H01029

193.0629905

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CONCORDBIO

51.97

14777.56

EPS(TTM)

Face Value()

Div & Yield %

27.18

0.53

Back

Dollex Agrotech standalone net profit rises 2629.41% in the March 2026 quarter

Jun 01,2026

Net profit of Dollex Agrotech rose 2629.41% to Rs 4.64 crore in the quarter ended March 2026 as against Rs 0.17 crore during the previous quarter ended March 2025. Sales declined 8.49% to Rs 108.59 crore in the quarter ended March 2026 as against Rs 118.67 crore during the previous quarter ended March 2025.

For the full year,net profit rose 1.69% to Rs 8.42 crore in the year ended March 2026 as against Rs 8.28 crore during the previous year ended March 2025. Sales declined 5.17% to Rs 225.16 crore in the year ended March 2026 as against Rs 237.43 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	108.59	118.67	-8	225.16	237.43	-5
OPM %	7.20	2.35	-	7.57	6.87	-
PBDT	7.00	1.62	332	13.62	13.01	5
PBT	6.26	0.99	532	10.63	10.49	1
NP	4.64	0.17	2629	8.42	8.28	2

78,428.95 -210.08 ( -0.27%)

53,210.99 704.96 (1.34%)

7,621.51 110.79 (1.48%)

63,983.92 229.02 (0.36%)

10,890.39 32.69 (0.30%)

95.40 -0.19 (-0.20%)

110.00 0.21 (0.19%)

128.60 0.50 (0.39%)

0.61 0.01 (2.47%)